XML 96 R82.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Options And Employee Stock Purchase Plan (Restricted Stock) (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Expected volatility 0.00% 28.12% 0.00%
Risk-free interest rate 0.00% 1.61% 0.00%
Restricted (Performance) Stock [Member]      
Underlying stock price at valuation date $ 63.73    
Expected volatility 29.80%    
Risk-free interest rate 1.51%    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Shares, Granted 106,780 0  
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested, Beginning of Period 704,804 814,050 1,178,371
Shares, Granted 296,414 234,540 226,864
Shares, Vested (255,503) (254,871) (546,115)
Shares, Canceled (40,700) (88,915) (45,070)
Nonvested, End of Period 705,015 704,804 814,050
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-Average Grant-Date Fair Value, Nonvested, Beginning of Period $ 39.08 $ 26.57 $ 17.86
Weighted-Average Grant-Date Fair Value, Granted 41.27 68.11 45.66
Weighted-Average Grant-Date Fair Value, Vested 31.27 25.16 15.63
Weighted-Average Grant-Date Fair Value, Canceled 63.95 40.97 35.55
Weighted-Average Grant-Date Fair Value, Nonvested, End of Period $ 41.40 $ 39.08 $ 26.57
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested, Beginning of Period 56,245 102,924 109,725
Shares, Granted 21,500 18,400 38,737
Shares, Vested (14,595) (23,221) (19,598)
Shares, Canceled (11,200) (41,858) (25,940)
Nonvested, End of Period 51,950 56,245 102,924
Shares, Vested and expected to vest 41,163    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Outstanding, Weighted-Average Remaining Contractual Life (in Years) 1 year 9 months 29 days    
Vested and expected to vest, Weighted-Average Remaining Contractual Life (in Years) 1 year 7 months 6 days    
Outstanding, Aggregate Intrinsic Value $ 4,249,510    
Vested and expected to vest, Aggregate Intrinsic Value $ 3,367,103